Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise (Q39441407)

12 September 2017

Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise (English)

1 reference

12 September 2017

Stephens RJ

1

1 reference

12 September 2017

Hopwood P

series ordinal

2

1 reference

12 September 2017

Girling DJ

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

12 September 2017

1 reference

12 September 2017

79

1 reference

12 September 2017

3-4

1 reference

12 September 2017

538-544

1 reference

A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362419

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10027327

12 December 2020

inferred from PubMed ID database lookup

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10027327

12 December 2020

inferred from PubMed ID database lookup

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10027327

12 December 2020

inferred from PubMed ID database lookup

Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Wor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Part

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Oral sucralfate in acute radiation oesophagitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690085

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690085

1 reference

12 September 2017

1 reference

12 September 2017

PubMed publication ID

10027327

1 reference